Published “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor” in Cell — cited 17,445 times.
- #crossref
- #research
- #work
Published “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor” in Cell — cited 17,445 times.
Captured 2026-08-17 from Crossref. The archived copy is preserved so this citation survives link rot.